Selective PDE III Inhibitors Flashcards
PDE III inhibitors decreases the degradation of cellular cAMP which results in (ACTION IN CARDIAC MUSCLE)
Increase levels of cAMP leads to an increase in intracellular calcium concentration in cardiac muscles and produces POSITIVE inotropic effects and increased speed of relaxation
Agents PDE III also called
cyclic AMP-PDE III inhibitors.
Effects of catecholamines are ________ why?
increased; because they also increased concentration of cAMP through beta-adrenergic receptors
Milrinone: Useful in the management of acute
acute left ventricular dysfunction as may follow cardiac surgery or an acute MI
What is milrinone?
A_________ derivative that is a _______ ________, PDEIII inhibitor that produces dose-dependent positive ________
and _________properties with minimal effect on ________ and ______ _______
A bipyridine derivative that is a selective, competitive, PDEIII inhibitor that produces dose-dependent positive inotropic
and vasodilating properties with minimal effect on heart rate and myocardial oxygen consumption
Milrinone
Better than inamrinone
Action of Milrinone : Increased are _____and _______
Decreased are :
Unchanged or slightly increased?
CO, Contractility
SVR, PVR, (mean pulmonary artery pressure)
afterload, preload, venous return
HR.
Mechanism of action of Milrinone
-positive lusitropic (myocardial relaxation) effect
facilitates diastolic relaxation, decreases right and left ventricular end- diastolic pressures (right and left heart filling pressures decreased)
decreases pulmonary capillary wedge pressure
decreased wall tension
Effects of milrinone on SV :
Decreased:
Afterload
Preload and venous return to the heart.
Compared with dobutamine, as
less tachycardia
move vasodilation
Greater decreases SVR and BP
More effective at decreasing cardiac filling
Compared with dobutamine, as Milrinone
less tachycardia
move vasodilation
Greater decreases SVR and BP
More effective at decreasing cardiac filling
Milrinone not used in
Severe obstructive aortic or pulmonic valvular disease
The inotropic effects of milrinone are decreased by _____? why?
ACIDOSIS; Presumably reflecting decreased cAMP formation in acidotic muscle
Milrinone should be avoided in severe Chronic HF why
Increased morbidity and mortality with chronic use.
Loading dose of milrinone
50mcg/kg administered over 10 MINUTES
followd by continuous infusion 0.375 -0.75 mcg/kg/min
Elimination half life of milrinone
- 3 hours
Elimination organ is ______ and_____ of milrinone is excreted ______. Therefore, dose should be decreased in patients with _________
Kidneys ; 80% unchanged in urine;
Renal insufficiency.
Adverse effects of MILRINONE
HYPOTENSION
What increases the risk of hypotension
What decreases the risk?
Loading dose
Slow administration
Milrinone can cause
Atrial or ventricular arrythmia
Nonsustained vtach or vfib
Inamrinone
Agent of choice is
does everything milrinone
Milrinone does it better
MILRINONE
Non-selective Phosphodiesterase Inhibitors
Theophylline and Aminophylline
Is structurally in the class of ________medications and is similar in structure to
methylxanthine ; Caffeine
Is a bronchodilating agent that also has anti-inflammatory, immunomodulatory and stimulatory properties
bronchodilating